Trial Profile
A Study to Evaluate the Efficacy of T-DM1 in Patients With Metastatic HER2-Positive Breast Cancer Previously Treated With Trastuzumab and Pertuzumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 23 Jun 2016 New trial record
- 13 Jun 2016 Results published in the Journal of Clinical Oncology
- 07 Jun 2016 Results (n=78) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology